Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis? (Q40158596)

18 September 2017

1 reference

title

Does drug therapy slow radiographic deterioration in rheumatoid arthritis? (English)

1 reference

18 September 2017

Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis? (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

5 October 2023

0 references

L. Iannuzzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6353231

5 October 2023

N. Dawson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6353231

5 October 2023

N. Zein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6353231

5 October 2023

I. Kushner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6353231

5 October 2023

language of work or name

English

0 references

publication date

1 October 1983

1 reference

18 September 2017

27 October 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6353231

full work available at URL

5 October 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM198310273091704

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

The New England Journal of Medicine

5 October 2023

published in

1 reference

18 September 2017

309

1 reference

18 September 2017

17

1 reference

18 September 2017

1023-1028

1 reference

18 September 2017

3

55

161

Bunch

1980

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

A Critique of Methodology in Studies of Anticoagulant Therapy for Acute Myocardial Infarction

5 October 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Reporting on methods in clinical trials

5 October 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Methodologic problems of exercise testing for coronary artery disease: groups, analysis and bias

5 October 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Gold Therapy in Rheumatoid Arthritis

5 October 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial

5 October 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

A controlled trial of gold salt therapy in rheumatoid arthritis

5 October 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Gold salts in the treatment of rheumatoid arthritis. A double-blind study

5 October 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen

5 October 2023

17

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis

5 October 2023

18

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year

5 October 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Chloroquine diphosphate in rheumatoid arthritis. A controlled trial

5 October 2023

20

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Bulletin on the rheumatic diseases

5 October 2023

21

13

287

Mainland

1962

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis

5 October 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Azathioprine in rheumatoid arthritis. A double-blind, cross over study

5 October 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

A Controlled Trial of Cyclophosphamide in Rheumatoid Arthritis

5 October 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Double-blind study of cyclophosphamide in rheumatoid arthritis

5 October 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Cyclophosphamide Therapy for Rheumatoid Arthritis

5 October 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Controlled trial of cyclophosphamide in rheumatoid arthritis

5 October 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

XLVIII. Efficacy of different research structures in preventing bias in the analysis of causation

5 October 2023

28

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Do drugs change the course of rheumatoid arthritis?

5 October 2023

32

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Relationship of radiological change to clinical outcome in rheumatoid arthritis

5 October 2023

33

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities

5 October 2023

35

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Effects of naproxen on connective tissue changes in the adjuvant arthritic rat

5 October 2023

37

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Studies on type II collagen-induced polyarthritis in rats. Effect of antiinflammatory and antirheumatic agents

5 October 2023

38

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

EMPIRE Rheumatism Council; multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results up to one year

5 October 2023

39

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

EMPIRE Rheumatism Council: multi-centre controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis; results of three years' treatment

5 October 2023

40

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial

5 October 2023

45

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine

5 October 2023

46

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

A multicentre1) controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage

5 October 2023

47

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial

5 October 2023

48

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

Azathioprine in Rheumatoid Arthritis

5 October 2023

49

1 reference

https://api.crossref.org/works/10.1056/NEJM198310273091704

5 October 2023

Identifiers

1 reference

18 September 2017

1 reference